Gymnemagenin

CAS No. 22467-07-8

Gymnemagenin ( —— )

Catalog No. M20418 CAS No. 22467-07-8

Gymnemagenin is a potent and selective antagonist for the β isoform of LXR it has antihyperglycemic activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 295 In Stock
10MG 444 In Stock
25MG 710 In Stock
50MG 963 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Gymnemagenin
  • Note
    Research use only not for human use.
  • Brief Description
    Gymnemagenin is a potent and selective antagonist for the β isoform of LXR it has antihyperglycemic activity.
  • Description
    Gymnemagenin is a potent and selective antagonist for the β isoform of LXR it has antihyperglycemic activity.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    LXR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    22467-07-8
  • Formula Weight
    506.7
  • Molecular Formula
    C30H50O6?
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:30 mg/mL (59.2 mM)
  • SMILES
    [H][C@@]12CC(C)(C)[C@@H](O)[C@H](O)[C@]1(CO)[C@@H](O)C[C@]1(C)C2=CC[C@]2([H])[C@@]3(C)CC[C@H](O)[C@@](C)(CO)[C@]3([H])CC[C@@]12C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kang M H Lee M S Choi M K et al. Hypoglycemic Activity of Gymnema sylvestre Extracts on Oxidative Stress and Antioxidant Status in Diabetic Rats[J]. Journal of Agricultural and Food Chemistry 2012 60(10):2517-2524.
molnova catalog
related products
  • debutylbupivacaine

    It is the intermediate of Ropivacaine Hydrochloride and Bupivacain.

  • K-604

    K-604 is a potent, selective and competitive ACAT-1 inhibitor with IC50 of 0.45 uM for human ACAT-1, displays 229-fold selectivity over ACAT-2.

  • Dimethyl DL-Glutamat...

    Dimethyl DL-glutamate is a cell-permeant glutamic acid derivative that enhances insulin release in response to glucose in isolated islets and in animal models of diabetes.